Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Berry

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Archives of Internal Medicine|January 14, 2004
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analysesCharles H Hennekens, Frank M Sacks, Andrew Tonkin, et al.
Cureus|April 7, 2023
Real World and Public Health Perspectives of Intraoperative Radiotherapy in Early-Stage Breast Cancer: A Multidisciplinary Analysis Beyond the Statistical FactsSrinivasan Vijayakumar, Mary R Nittala, Vedanth Buddala, et al.
Plos One|July 27, 2016
High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1Jennifer L Schehr, Zachery D Schultz, Jay W Warrick, et al.
JAMA|January 28, 2010
Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trialDavid J Wilber, Carlo Pappone, Petr Neuzil, et al.
American Journal of Surgery|December 20, 2016
A randomized, blinded, multicenter trial of a gentamicin vancomycin gel (DFA-02) in patients undergoing abdominal surgeryElliott Bennett-Guerrero, Scott M Berry, Sergio D Bergese, et al.
Biomarker Research|April 26, 2022
Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancerJennifer L Schehr, Nan Sethakorn, Zachery D Schultz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2016
Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte IsolationJamie M Sperger, Lindsay N Strotman, Allison Welsh, et al.
Annals of the American Thoracic Society|February 2, 2018
Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical TrialRoger J Lewis, Derek C Angus, Pierre-François Laterre, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2021
Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 studyNuria Carrillo, May C Malicdan, Petcharat Leoyklang, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 2, 2017
Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methodsTudor G Jovin, Jeffrey L Saver, Marc Ribo, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Archives of Internal Medicine|January 14, 2004
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analysesCharles H Hennekens, Frank M Sacks, Andrew Tonkin, et al.
Cureus|April 7, 2023
Real World and Public Health Perspectives of Intraoperative Radiotherapy in Early-Stage Breast Cancer: A Multidisciplinary Analysis Beyond the Statistical FactsSrinivasan Vijayakumar, Mary R Nittala, Vedanth Buddala, et al.
Plos One|July 27, 2016
High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1Jennifer L Schehr, Zachery D Schultz, Jay W Warrick, et al.
JAMA|January 28, 2010
Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trialDavid J Wilber, Carlo Pappone, Petr Neuzil, et al.
American Journal of Surgery|December 20, 2016
A randomized, blinded, multicenter trial of a gentamicin vancomycin gel (DFA-02) in patients undergoing abdominal surgeryElliott Bennett-Guerrero, Scott M Berry, Sergio D Bergese, et al.
Biomarker Research|April 26, 2022
Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancerJennifer L Schehr, Nan Sethakorn, Zachery D Schultz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2016
Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte IsolationJamie M Sperger, Lindsay N Strotman, Allison Welsh, et al.
Annals of the American Thoracic Society|February 2, 2018
Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical TrialRoger J Lewis, Derek C Angus, Pierre-François Laterre, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2021
Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 studyNuria Carrillo, May C Malicdan, Petcharat Leoyklang, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 2, 2017
Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methodsTudor G Jovin, Jeffrey L Saver, Marc Ribo, et al.
Pageof 12